Zoetis Inc. Files 8-K with Financial Statements

TL;DR

Zoetis filed an 8-K on 5/21/25, mostly financial docs. Nothing major to see here.

AI Summary

On May 21, 2025, Zoetis Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating a routine disclosure of financial information. No specific material events or transactions are detailed in the provided excerpt, suggesting it's a standard filing.

Why It Matters

This filing provides updated financial information for Zoetis Inc., which is important for investors to assess the company's performance and financial health.

Risk Assessment

Risk Level: low — The filing appears to be a routine disclosure of financial statements and exhibits, with no indication of significant negative events or changes.

Key Numbers

• 001-35797 — SEC File Number (Identifies the specific filing with the SEC.)
• 46-0696167 — EIN (Employer Identification Number for tax purposes.)

Key Players & Entities

• Zoetis Inc. (company) — Registrant
• May 21, 2025 (date) — Date of report
• Delaware (jurisdiction) — State of incorporation
• 46-0696167 (id) — I.R.S. Employer Identification No.
• 10 Sylvan Way Parsippany New Jersey 07054 (address) — Address of principal executive offices
• 973-822-7000 (phone) — Registrant's telephone number

FAQ

From the Filing

0001555280-25-000209.txt : 20250521 0001555280-25-000209.hdr.sgml : 20250521 20250521162257 ACCESSION NUMBER: 0001555280-25-000209 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250521 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250521 DATE AS OF CHANGE: 20250521 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zoetis Inc. CENTRAL INDEX KEY: 0001555280 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 460696167 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35797 FILM NUMBER: 25973452 BUSINESS ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 973-822-7000 MAIL ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 8-K 1 zts-20250521.htm 8-K zts-20250521 0001555280 false 0001555280 2025-05-21 2025-05-21 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.  20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 21, 2025 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incorporation) Number) Identification No.) 10 Sylvan Way Parsippany New Jersey 07054 (Address of principal executive offices) (Zip Code) ( 973 ) 822-7000 (Registrant's telephone number, including area code) Not Applicable (Former Name or Former Address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐     Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b)) ☐     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share ZTS New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).                                      Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 7.01. Regulation FD Disclosure. On May 21 2025, the Company declared a dividend of $0.500 per share for the third quarter of 2025. The dividend will be paid on September 3, 2025, to all holders of record of the Company’s common stock as of the close of business on July 18, 2025. The information set forth under this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any filing under the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing, unless expressly incorporate